Polymodal Reconnaissance in Urothelial Cancer Deploying Epigenetic Network and Transcriptome Analyses

• Conditions: C67; C66; C65; Malignant neoplasm of bladder; Malignant neoplasm of ureter; Malignant neoplasm of renal pelvis

• Registration Number: DRKS00013039
• Lead Sponsor: Klinik für Urologie Universitätsklinikum Freiburg i. Br.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-03-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 156

Inclusion Criteria

Indication to transurethral or open resection of urothelial cancer. Consent provided.

Exclusion Criteria

Consent not provided. Consent cannot be given by the patient themselve.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Molecular and histological characterization.

Secondary Outcome Measures

Name	Time	Method
Correlation to clinical data. Prediction regarding response to therapy, progress, recurrence.